Osteoarthritis of the hip Osteonecrosis of the hip
Conditions
Interventions
None listed
Sponsors
Kanazawa university hospital, Department of Orthopaedic surgery (Division of Rehabilitation)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patients that primary total hip arthroplasty using Accolade 2 is planned by a normal medical service under health insurance. The patients that a document agreement by the free will of the patients person himself was obtained after enough understanding after having received enough explanation on this study participation. The patients with the intention to participate in this study during an observation period.
Exclusion criteria
Exclusion criteria: Patients with infection disease or the patients who are of high at risk. Patients with a history of surgery such as the osteotomy on treated femur. Extensive obese patients with BMI 40 or more. Patients who have pregnant or pregnant possibilities. Patients with systematic disease, neuromuscular disease, or sensory nerve disease, that the physician who has responsibility with this study think it may influence the evaluation. Patients with immunosuppressive drug or continuous steroid use, that the physician who has responsibility with this study think it may influence the evaluation. Patients who judged a study responsibility physician not to be eligible by other clear reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Radiographic evaluation (CT, X-ray) and clinical evaluation (clinical score, patient-oriented QOL evaluation) until two years after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse event | — |
Countries
Japan
Contacts
Public ContactTamon Kabata
Kanazawa university hospital Department of Orthopaedic surgery (Division of Rehabilitation)
Outcome results
None listed